Paul Mampilly on the Use of Blockchain Technology in the Health Sector

Paul Mampilly is an author of many business-related articles with the aim of helping his readers to make informed investment decisions. Paul Mampilly works as an editor at the Banyan Hill Publishing. Blockchain has become a global topic and is gaining prominence. It is a form of digital record-keeping. It was developed in 2008 to avoid the challenges of the traditional record-keeping. With the blockchain technology, you can keep track of many transactions and make entries easy for use by the public. It facilitates the use of cryptocurrencies. Privacy is a concern for many people in the digital era and the use of blockchain guarantees that. You can transact online without exposing your personal information to the third parties.

Many organizations have also adopted the innovation to ensure that they are safe from cyber security threats such as hacking. A person can only access your information if only you permit them to do so. Unlike some other innovations in the market today, you can set some conditions upon which the users can retrieve the information provided. For that reason, the cases of medical fraud are expected to reduce significantly. The blockchain technology is expected to affect several industries in the country. Some investors in the medical industry are already working on how on its application in service delivery. Paul MamPilly has written articles on the innovation.

In one of the articles, he talks about the benefits of using E-pills. Paul Mampilly reveals that the blockchain technology could benefit the patients by informing them about the effectiveness of prescription medications. According to him, it would involve the use of pills fitted with digital sensors that would be linked to a mobile application where you can view the details on whether the capsules will work well or whether there is a need to seek further medical advice. The medical practitioners can access the information conveyed by the digital sensors, and that will help them to identify the patients who fail to follow the recommended prescriptions. The drug manufacturers can also use the data to produce the ones that are more effective.